1. Controls of Hyperglycemia Improves Dysregulated Microbiota in Diabetic Mice.
- Author
-
Cao M, Peng Y, Lu Y, Zou Z, Chen J, Bottino R, Knoll M, Zhang H, Lin S, Pu Z, Sun L, Fang Z, Qiu C, Dai Y, Cai Z, and Mou L
- Subjects
- Animals, Bacteria classification, Bacteria genetics, Biomarkers blood, Blood Glucose metabolism, Diabetes Mellitus, Experimental blood, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental microbiology, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 chemically induced, Diabetes Mellitus, Type 1 microbiology, Dysbiosis, Feces microbiology, Islets of Langerhans Transplantation, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Ribotyping, Streptozocin, Tissue Culture Techniques, Mice, Bacteria growth & development, Blood Glucose drug effects, Diabetes Mellitus, Experimental therapy, Diabetes Mellitus, Type 1 therapy, Gastrointestinal Microbiome, Glycemic Control, Hypoglycemic Agents pharmacology, Insulin pharmacology
- Abstract
Background: Type 1 diabetes (T1DM) is a chronic autoimmune disease characterized by T-cell-mediated destruction of insulin-producing beta cells. Evidence shows that patients with T1DM and mice used in specific diabetic models both exhibit changes in their intestinal microbiota and dysregulated microbiota contributes to the pathogenesis of T1DM. Islet transplantation (Tx) is poised to play an important role in the treatment of T1DM. However, whether treatment of T1DM with islet Tx can rescue dysregulated microbiota remains unclear., Methods: In this study, we induced diabetic C57BL/6 mice with streptozotocin. Then treatment with either insulin administration, or homogenic or allogenic islet Tx was performed to the diabetic mice. Total DNA was isolated from fecal pellets and high-throughput 16S rRNA sequencing was used to investigate intestinal microbiota composition., Results: The overall microbial diversity was comparable between control (nonstreptozotocin treated) and diabetic mice. Our results showed the ratio of the Bacteroidetes: Firmicutes between nondiabetic and diabetic mice was significant different. Treatment with islet Tx or insulin partially corrects the dysregulated bacterial composition. At the genus level, Bacteroides, Odoribacter, and Alistipes were associated with the progression and treatment efficacy of the disease, which may be used as a biomarker to predict curative effect of treatment for patients with T1DM., Conclusions: Collectively, our results indicate that diabetic mice show changed microbiota composition and that treatment with insulin and islet Tx can partially correct the dysregulated microbiota., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF